Clinical Trial Update: Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a perioperative bundle including hydrocortisone, octreotide, and a teres ligament patch to reduce postoperative complications …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ampullary Carcinoma
• Carcinoma of the Head of the Pancreas
• Cholangiocarcinoma
• Duodenal Adenocarcinoma
• Intraductal Papillary Mucinous Neoplasm of the Pancreas
• Mucinous Cystic Neoplasm of the Pancreas
• Pancreatic Ductal Adenocarcinoma
• Pancreatic Neuroendocrine Tumor

Drugs mentioned

• HYDROCORTISONE (HYDROCORTISONE)
• Sandostatin (Octreotide acetate)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Pancreas Head Cancer, Pancreas Adenocarcinoma | Phase 4 | Status: RECRUITING